These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20614464)

  • 1. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
    Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Ang C; Chan KK; Bryant A; Naik R; Dickinson HO
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007697. PubMed ID: 21491400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
    Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
    Wuntakal R; Seshadri S; Montes A; Lane G
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Morrison J; Thoma C; Goodall RJ; Lyons TJ; Gaitskell K; Wiggans AJ; Bryant A
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007927. PubMed ID: 30321910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).
    Gurumurthy M; Bryant A; Shanbhag S
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006912. PubMed ID: 24753008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenterative surgery for recurrent gynaecological malignancies.
    Ang C; Bryant A; Barton DP; Pomel C; Naik R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010449. PubMed ID: 24497188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
    Eleje GU; Eke AC; Igberase GO; Igwegbe AO; Eleje LI
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011000. PubMed ID: 25932968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
    Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for the treatment of borderline ovarian tumours.
    Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy for the management of endometrial cancer.
    Frost JA; Webster KE; Bryant A; Morrison J
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007585. PubMed ID: 28968482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.
    Cousins SE; Tempest E; Feuer DJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002764. PubMed ID: 26727399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
    Eleje GU; Eke AC; Igberase GO; Igwegbe AO; Eleje LI
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011000. PubMed ID: 30888060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007927. PubMed ID: 21975775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
    Galaal K; Naik R; Bristow RE; Patel A; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007822. PubMed ID: 20556785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for relapse of ovarian cancer.
    Williams C; Simera I; Bryant A
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD001034. PubMed ID: 20238312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.